Effect of diazoxide on golden hamsters with chronic hypoglycemia due to a transplantable islet-cell tumor.
D007516:Adenoma, Islet Cell / Q000097:blood* / Q000150:complications / Q000378:metabolism; D000284:Administration, Oral; D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D006224:Cricetinae; D003981:Diazoxide / Q000008:administration & dosage / Q000494:pharmacology*; D004837:Epinephrine / Q000378:metabolism; D005215:Fasting; D007003:Hypoglycemia / Q000097:blood* / Q000209:etiology; D007274:Injections, Intraperitoneal; D007328:Insulin / Q000097:blood; D009638:Norepinephrine / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D011863:Radioimmunoassay; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D012110:Reserpine; D011433:Propranolol; D003981:Diazoxide; D009638:Norepinephrine; D004837:Epinephrine